ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Recalls and Alerts

Class 4 Caution in Use

Class 4 caution in use-Vyvgart 1000mg solution for injection

Argenx BV have informed MHRA that the Patient Information Leaflet (PIL) in the affected packs incorrectly contains reference to two subcutaneous injection sites. Only subcutaneous injection to the abdomen is permitted.

 

MHRA Drug alert date: 19th December 2024

 

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-argenx-bv-vyvgart-1000-mg-solution-for-injection-el-24-a-slash-63?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ab2d5607-6db9-4cc3-9766-16136bc8802d&utm_content=immediately

 

Pip code

Product description

Supplier

Batch Numbers

ALLIANCE DO NOT STOCK

Vyvgart 1000 mg solution for injection

Argenx BV

 

P99834CE  P99834CJ  P99834CK  P99842CH

 

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For medical information enquiries please contact ukmedinfo@argenx.com or +44 (0)20 4532 4016.

 

For stock control enquiries please contact rpi@argenx.com or +44 (0)7801 748936.